205 related articles for article (PubMed ID: 9591588)
21. The clinical utility of Tc-99m sestamibi scintimammography in detecting multicentric breast cancer.
Vargas HI; Agbunag RV; Kalinowski A; Tolmos J; Klein SR; Diggles L; Khalkhali I
Am Surg; 2001 Dec; 67(12):1204-8. PubMed ID: 11768831
[TBL] [Abstract][Full Text] [Related]
22. Tc-99m-tetrofosmin scintimammography: a prospective study in primary breast lesions.
Lind P; Gallowitsch HJ; Kogler D; Kresnik E; Mikosch P; Gomez I
Nuklearmedizin; 1996 Dec; 35(6):225-9. PubMed ID: 8976502
[TBL] [Abstract][Full Text] [Related]
23. Can scintimammography reduce "unnecessary" biopsies?
Flanagan DA; Gladding SB; Lovell FR
Am Surg; 1998 Jul; 64(7):670-2; discussion 673. PubMed ID: 9655280
[TBL] [Abstract][Full Text] [Related]
24. Scintimammography using Tc-99m tetrofosmin.
Lind P; Umschaden HW; Forsthuber E; Oman J; Kerschbaumer K; Gallowitsch HJ; Mikosch P; Kresnik E; Molnar M; Gomez I
Acta Med Austriaca; 1997; 24(2):50-4. PubMed ID: 9227787
[TBL] [Abstract][Full Text] [Related]
25. Scintimammography with 99mTc-MDP in the detection of primary breast cancer.
Piccolo S; Lastoria S; Muto P; Bazzicalupo L; Bartiromo A; Salvatore M
Q J Nucl Med; 1997 Sep; 41(3):225-30. PubMed ID: 9274130
[TBL] [Abstract][Full Text] [Related]
26. Influence of single photon emission computed tomography (SPECT) reconstruction algorithm on diagnostic accuracy of parathyroid scintigraphy: Comparison of iterative reconstruction with filtered backprojection.
Gedik GK; Sari O
Indian J Med Res; 2017 Apr; 145(4):479-487. PubMed ID: 28862179
[TBL] [Abstract][Full Text] [Related]
27. 99mTc sestamibi scintimammography. Screening mammographic non-palpable suspicious breast lesions: preliminary results.
Bekiş R; Derebek E; Balci P; Koçdor MA; Değirmenci B; Canda T; Durak H
Nuklearmedizin; 2004 Feb; 43(1):16-20. PubMed ID: 14978536
[TBL] [Abstract][Full Text] [Related]
28. Prone scintimammography in patients with suspicion of carcinoma of the breast.
Khalkhali I; Mena I; Jouanne E; Diggles L; Venegas R; Block J; Alle K; Klein S
J Am Coll Surg; 1994 May; 178(5):491-7. PubMed ID: 8167887
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of mammographic breast lesions with Tc-99m sestamibi scintimammography and contrast enhanced MRI.
Sommer H; Tiling R; Pechmann M; Kindermann G; Kress K; Moser R; Tatsch K; Hahn K; Pfluger T; Assemi C
Zentralbl Gynakol; 1997; 119(1):6-11. PubMed ID: 9050197
[TBL] [Abstract][Full Text] [Related]
30. Double-phase 99mTc-sestamibi scintimammography and trans-scan in diagnosing breast cancer.
Melloul M; Paz A; Ohana G; Laver O; Michalevich D; Koren R; Wolloch Y; Gal R
J Nucl Med; 1999 Mar; 40(3):376-80. PubMed ID: 10086698
[TBL] [Abstract][Full Text] [Related]
31. 18F-FDG PET and 99mTc-sestamibi scintimammography for monitoring breast cancer response to neoadjuvant chemotherapy: a comparative study.
Tiling R; Linke R; Untch M; Richter A; Fieber S; Brinkbäumer K; Tatsch K; Hahn K
Eur J Nucl Med; 2001 Jun; 28(6):711-20. PubMed ID: 11440031
[TBL] [Abstract][Full Text] [Related]
32. 99mTc-3P4-RGD2 scintimammography in the assessment of breast lesions: comparative study with 99mTc-MIBI.
Ma Q; Chen B; Gao S; Ji T; Wen Q; Song Y; Zhu L; Xu Z; Liu L
PLoS One; 2014; 9(9):e108349. PubMed ID: 25250628
[TBL] [Abstract][Full Text] [Related]
33. Comparison of quantitative and visual analysis of Tc-99m MIBI scintimammography for detection of primary breast cancer.
Kim SJ; Kim IJ; Bae YT; Kim YK; Kim DS
Eur J Radiol; 2005 Feb; 53(2):192-8. PubMed ID: 15664282
[TBL] [Abstract][Full Text] [Related]
34. Differentiation of benign and malignant breast lesions: MR imaging versus Tc-99m sestamibi scintimammography.
Helbich TH; Becherer A; Trattnig S; Leitha T; Kelkar P; Seifert M; Gnant M; Staudenherz A; Rudas M; Wolf G; Mostbeck GH
Radiology; 1997 Feb; 202(2):421-9. PubMed ID: 9015068
[TBL] [Abstract][Full Text] [Related]
35. Receiver operating characteristic evaluation of iterative reconstruction with attenuation correction in 99mTc-sestamibi myocardial SPECT images.
LaCroix KJ; Tsui BM; Frey EC; Jaszczak RJ
J Nucl Med; 2000 Mar; 41(3):502-13. PubMed ID: 10716326
[TBL] [Abstract][Full Text] [Related]
36. Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up.
Khalkhali I; Cutrone J; Mena I; Diggles L; Venegas R; Vargas H; Jackson B; Klein S
J Nucl Med; 1995 Oct; 36(10):1784-9. PubMed ID: 7562043
[TBL] [Abstract][Full Text] [Related]
37. Limited value of scintimammography and contrast-enhanced MRI in the evaluation of microcalcification detected by mammography.
Tiling R; Khalkhali I; Sommer H; Linke R; Moser R; Willemsen F; Pfluger T; Tatsch K; Hahn K
Nucl Med Commun; 1998 Jan; 19(1):55-62. PubMed ID: 9515547
[TBL] [Abstract][Full Text] [Related]
38. The value of early and double phase 99Tcm-sestamibi scintimammography in the diagnosis of breast cancer.
Paz A; Melloul M; Cytron S; Koren R; Ohana G; Michalevich D; Gal R; Wolloch Y
Nucl Med Commun; 2000 Apr; 21(4):341-8. PubMed ID: 10845222
[TBL] [Abstract][Full Text] [Related]
39. New method for breast cancer detection using TC-99m sestamibi scintimammography.
Yuen-Green M; Wasnich R; Caindec-Ranchez S; Davis J
Hawaii Med J; 1996 Feb; 55(2):26-8. PubMed ID: 8820628
[TBL] [Abstract][Full Text] [Related]
40. The usefulness of 99mTc-tetrofosmin SPECT scintimammography in the detection of small size primary breast carcinomas.
Spanu A; Schillaci O; Meloni GB; Porcu A; Cottu P; Nuvoli S; Falchi A; Chessa F; Solinas ME; Madeddu G
Int J Oncol; 2002 Oct; 21(4):831-40. PubMed ID: 12239623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
